Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Josep Dalmau, Amy J. Gleichman, Ethan G. Hughes et al. · The Lancet Neurology · 2008 · 3.4K citations · Full text

Autoimmune Disease, Anti-nmda-receptor Encephalitis, Medicine +12

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Maarten J. Titulaer, Lindsey McCracken, Iñigo Gabilondo et al. · The Lancet Neurology · 2013 · 3K citations · Full text

Prognostic Factors, Translational Medicine, Neurobiology Of Disease +14

N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

Sarosh R. Irani, Katarzyna D. Bera, Patrick Waters et al. · Brain · 2010 · 1K citations · Full text

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

Divyanshu Dubey, Sean J. Pittock, Cecilia R. Kelly et al. · Annals of Neurology · 2018 · 723 citations · Full text

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 679 citations

Neurobiology Of Disease, Ophthalmology, Neurological Disorder +5